Daiwa Securities Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,067
| Closed | -$753K | – | 1422 |
|
|
2022
Q3 | $753K | Buy |
3,067
+167
| +6% | +$41K | 0.01% | 706 |
|
|
2022
Q2 | $718K | Buy |
2,900
+39
| +1% | +$9.66K | 0.01% | 738 |
|
|
2022
Q1 | $948K | Buy |
2,861
+173
| +6% | +$57.3K | 0.01% | 716 |
|
|
2021
Q4 | $965K | Buy |
2,688
+168
| +7% | +$60.3K | 0.01% | 717 |
|
|
2021
Q3 | $820K | Buy |
2,520
+49
| +2% | +$15.9K | 0.01% | 728 |
|
|
2021
Q2 | $771K | Sell |
2,471
-728
| -23% | -$227K | 0.01% | 726 |
|
|
2021
Q1 | $1.02M | Buy |
3,199
+932
| +41% | +$297K | 0.01% | 612 |
|
|
2020
Q4 | $735K | Buy |
2,267
+80
| +4% | +$25.9K | 0.01% | 657 |
|
|
2020
Q3 | $606K | Buy |
2,187
+61
| +3% | +$16.9K | 0.01% | 637 |
|
|
2020
Q2 | $309K | Hold |
2,126
| – | – | 0.01% | 664 |
|
|
2020
Q1 | $309K | Buy |
2,126
+150
| +8% | +$21.8K | ﹤0.01% | 764 |
|
|
2019
Q4 | $337K | Hold |
1,976
| – | – | ﹤0.01% | 811 |
|
|
2019
Q3 | $352K | Buy |
1,976
+371
| +23% | +$66.1K | ﹤0.01% | 764 |
|
|
2019
Q2 | $418K | Hold |
1,605
| – | – | ﹤0.01% | 707 |
|
|
2019
Q1 | $458K | Sell |
1,605
-115
| -7% | -$32.8K | ﹤0.01% | 670 |
|
|
2018
Q4 | $559K | Buy |
1,720
+205
| +14% | +$66.6K | 0.01% | 569 |
|
|
2018
Q3 | $681K | Buy |
1,515
+80
| +6% | +$36K | 0.01% | 572 |
|
|
2018
Q2 | $587K | Buy |
+1,435
| New | +$587K | ﹤0.01% | 605 |
|